RVMD
Revolution Medicines, Inc. · Healthcare
Chief Development Officer Alan B. Sandler sold $68K of Revolution Medicines, Inc.
Sold$67,941
$199.24Price
341Shares
−1%Stake
What RVMD did after the filing
- The stock from Mon, Sep 21 open, $192.60
- −2.9%
- S&P 500, same days
- −0.8%
24 of 30 trading days so far, to the Oct 23 close.
Traded Wed, Sep 16. Filed Fri, Sep 18, 6:06 PM ET, after the close. Returns use the Sep 21 open and the Oct 23 close. Not investment advice.